Carpal Tunnel Syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Intervention group 1: patients received an injection of 0.5 mL of 2% Lidocaine with 1 mL of 2% Hyaluronic acid. Intervention 2: Control group: patients received 0.5 mL of 2% Lidocaine
Sponsors
Research Assistant of Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patient aged between 18 and 85 years. Patient with signs of carpal tunnel syndrome in the last 3 months. Patient with mild to moderate carpal tunnel syndrome according to electrodiagnostic criteria (modified Stevens criteria). Patient with pain intensity of 4 and more.
Exclusion criteria
Exclusion criteria: Severe Carpal Tunnel Syndrome requiring surgical intervention. Pregnancy and malignancy Concomitant neuropathy or radiculopathy. Patient with allergic reactions to Lidocaine, Hyaluronic acid and Hyaluronidase History of steroid injection into the Carpal Tunnel in the last 3 months. History of metabolic diseases such as diabetes and thyroid, rheumatoid arthritis. Patient with thoracic outlet syndrome (TOS). Previous Carpal Tunnel release surgery . Patient with severe atrophy of the tendon .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom severity scale index in patients with CTS. Timepoint: Before the study,10 weeks after intervention,29 weeks after intervention. Method of measurement: Boston Carpal Tunnel Questionnaire (BCTQ).;Functional severity scale in patients with CTS. Timepoint: Before the study,10 weeks after intervention,29 weeks after intervention. Method of measurement: Boston Carpal Tunnel Questionnaire (BCTQ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain index in patients with carpal tunnel syndrome. Timepoint: Before the study,10 weeks after intervention,29 weeks after intervention. Method of measurement: Visual Analog Scale.;Median nerve cross sectional area. Timepoint: Before the study,10 weeks after intervention,29 weeks after intervention. Method of measurement: By Ultrasound.;Severity of carpal tunnel syndrome . Timepoint: Before the study,10 weeks after intervention,20 weeks after intervention. Method of measurement: Based on Steven's modified criteria.;Patient satisfaction. Timepoint: Before intervention ,10 week after injection. Method of measurement: Likert 5 score questionnare.;Median peak sensory latency at wrist. Timepoint: Before intervention ,10 weeks and 20 weeks after injection. Method of measurement: Electrodiagnostic evaluation.;Median onset motor latency at wrist. Timepoint: Before intervention ,10 weeks and 20 weeks after injection. Method of measurement: Electrodiagnostic evaluation.;Motor wave amplitude of the median nerve in the wrist. Timepoint: Before intervention ,10 weeks and 20 weeks after injection. Method of measurement: Electrodiagnostic evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtie Tehrani nejd
Shahid Beheshti University of Medical Sciences
Outcome results
None listed